Keyphrases
Antigen-specific
33%
Antitumor Immune Response
33%
Cancer Chemotherapeutics
33%
Cancer Patients
33%
Chemoradiation
33%
Cisplatin
33%
Clinical Significance
33%
Cytokine Secretion
33%
Cytotoxic Effect
33%
Death Receptor Ligand
100%
Dual Action
33%
Enhanced Recognition
33%
Further Analysis
33%
Head-and-neck Cancer
33%
Human DCs
33%
Human Tumor Cells
33%
Human-to-human
33%
Immune Response
100%
Immunostimulatory
66%
In Cancer
33%
Inhibitory Mechanism
66%
Inhibitory Molecules
33%
Inhibitory Pathways
33%
Platinum Compounds
33%
Platinum Drugs
100%
Platinum-based
33%
Platinum-based Anticancer Drugs
33%
Programmed Death-ligand 1 (PD-L1)
100%
Recurrence-free Survival
33%
Reduced Expression
33%
T Cells
100%
Th1 Cytokines
33%
Therapeutic Intervention
33%
Therapeutic Use
33%
Tumor
33%
Tumor Cells
66%
Tumor Immunity
33%
Tumor Microenvironment
33%
Medicine and Dentistry
Anticarcinogen
20%
Antigen Specificity
20%
Chemoradiotherapy
20%
Cisplatin
20%
Cytokine Release
20%
Cytotoxicity
20%
Death Receptor
60%
Downregulation
40%
Head and Neck Cancer
20%
Immune Response
100%
Immunity
40%
Immunosuppressive Drug
20%
Malignant Neoplasm
100%
Neoplasm
20%
Patient-Data
20%
Platinum Derivative
20%
Recurrence Free Survival
20%
STAT6 Protein
100%
T Cell
60%
Tumor Cell
60%
Tumor Microenvironment
20%
Immunology and Microbiology
Antigen Specificity
20%
Cytokine Release
20%
Cytotoxicity
20%
Death Receptor
60%
Downregulation
40%
Immune Response
100%
Immunity
40%
Immunosuppressive Drug
20%
Neck
20%
Patient Coding
20%
Recurrence Free Survival
20%
STAT6
100%
T Cell
60%
Tumor Cell
60%
Pharmacology, Toxicology and Pharmaceutical Science
Anticarcinogen
20%
Chemoradiation Therapy
20%
Cisplatin
20%
Cytokine
20%
Cytotoxicity
20%
Death Receptor
60%
Head and Neck Cancer
20%
Immunosuppressive Agent
20%
Malignant Neoplasm
100%
Neoplasm
80%
Platinum Derivative
20%
Recurrence Free Survival
20%
STAT6 Protein
100%
Tumor Microenvironment
20%